The natural history of EGFR and EGFRvIII in glioblastoma patients
暂无分享,去创建一个
David J. Yang | Dima Suki | K. Aldape | A. Heimberger | D. Suki | W. Shi | Kenneth Aldape | Amy B Heimberger | Weiming Shi | David Yang
[1] D. Nelson,et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. , 1993, Journal of the National Cancer Institute.
[2] P. Kolm,et al. Epidermal growth factor receptor: an independent predictor of survival in astrocytic tumors given definitive irradiation. , 1996, International journal of radiation oncology, biology, physics.
[3] R. Sankila,et al. A population‐based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984 , 1991, Cancer.
[4] Ochi,et al. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas , 1998, Neuropathology and applied neurobiology.
[5] S. Brem,et al. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. , 1998, Journal of neurosurgery.
[6] Caterina Giannini,et al. Immunohistochemical Detection of EGFRvIII in High Malignancy Grade Astrocytomas and Evaluation of Prognostic Significance , 2004, Journal of neuropathology and experimental neurology.
[7] Susan M. Chang,et al. Glioblastoma Patients Epidermal Growth Factor Receptor , and Survival in Analysis of Complex Relationships between Age , p 53 , Updated , 2001 .
[8] Douglas C. Miller,et al. Survival of Patients with Glioblastoma Multiforme is not Influenced by Altered Expression of P16, P53, EGFR, MDM2 or Bcl‐2 Genes , 1998, Brain pathology.
[9] G Milano,et al. Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] R. McLendon,et al. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. , 1997, Cancer research.
[11] D.,et al. Regression Models and Life-Tables , 2022 .
[12] V. P. Collins,et al. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. , 1994, Oncogene.
[13] R. Bjerkvig,et al. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas. , 1997, Invasion & metastasis.
[14] Kenji Tada,et al. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. , 2003, Cancer research.
[15] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[16] J. Cairncross,et al. Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. , 1989, Journal of neurosurgery.
[17] O D Laerum,et al. Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. , 1990, Cancer research.
[18] R. Fimmers,et al. Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas. , 1996, Journal of neurosurgery.
[19] C. James,et al. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. , 2001, Journal of the National Cancer Institute.
[20] David J. Yang,et al. Prognostic Effect of Epidermal Growth Factor Receptor and EGFRvIII in Glioblastoma Multiforme Patients , 2005, Clinical Cancer Research.
[21] P. Kleihues,et al. Predominant Expression of Mutant EGFR (EGFRvIII) is Rare in Primary Glioblastomas , 2004, Brain pathology.
[22] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[23] C. James,et al. Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas. , 1998, International journal of oncology.